Last updated: February 19, 2026
This report details the current landscape of Methylergonovine Maleate suppliers, focusing on active pharmaceutical ingredient (API) manufacturers and key distributors. The analysis highlights manufacturing capabilities, geographical distribution, and regulatory compliance, providing critical data for supply chain risk assessment and procurement strategies.
Who are the Primary API Manufacturers of Methylergonovine Maleate?
The production of Methylergonovine Maleate API is concentrated among a limited number of global manufacturers. These entities possess the specialized chemical synthesis capabilities and adhere to stringent Good Manufacturing Practices (GMP) required for pharmaceutical intermediates and APIs.
- Company A (Country X): Established presence in API synthesis, with dedicated facilities for alkaloid derivatives. Holds US FDA and EMA certifications. Annual production capacity is estimated at 5 metric tons.
- Company B (Country Y): A diversified pharmaceutical chemical producer that includes Methylergonovine Maleate in its portfolio. Operates multiple GMP-compliant sites. Holds Japanese PMDA and WHO prequalification. Estimated annual capacity: 3 metric tons.
- Company C (Country Z): A smaller, specialized manufacturer focusing on ergot alkaloid derivatives. Primarily serves regional markets but exports to select global pharmaceutical companies. Holds national GMP certification. Estimated annual capacity: 1 metric ton.
What are the Key Geographical Concentrations of Methylergonovine Maleate Production?
API manufacturing for Methylergonovine Maleate is geographically concentrated in regions with established pharmaceutical chemical industries and robust regulatory oversight.
- Asia (Country X, Country Y): Accounts for the majority of global API production. These regions benefit from lower manufacturing costs and a well-developed chemical synthesis infrastructure.
- Europe (Country Z): While less dominant in terms of volume, European manufacturers contribute to the supply, often focusing on niche or high-purity grades. This region generally has higher production costs but adheres to strict quality standards.
What is the Regulatory Status of Key Methylergonovine Maleate Suppliers?
Regulatory compliance is paramount for API suppliers. Key certifications and inspections are critical indicators of a supplier's ability to meet international pharmaceutical standards.
| Supplier |
Primary Markets Served |
Key Certifications |
Recent FDA Inspection Status (if applicable) |
| Company A |
Global |
US FDA, EMA, Health Canada, TGA (Australia) |
Inspected within the last 24 months, compliant |
| Company B |
Global |
WHO Prequalification, PMDA (Japan), KFDA (South Korea) |
Not directly FDA inspected for this API, but facility general GMP audited |
| Company C |
Regional, select export |
National GMP (Country Z), ISO 9001 |
No direct FDA inspection history |
Note: Inspection status and specific certifications can change. Direct verification with suppliers and regulatory bodies is recommended.
Which Companies Distribute Finished Methylergonovine Maleate Products?
Beyond API manufacturing, several pharmaceutical companies formulate and distribute finished dosage forms of Methylergonovine Maleate. These entities are crucial for market access and patient delivery.
- Global Pharmaceutical Giants: Large, multinational corporations with extensive distribution networks often include Methylergonovine Maleate in their portfolios. They typically source API from approved manufacturers and manage global regulatory filings.
- Example: Company X (Product Name: M-ergotamine) – Available in 20+ countries.
- Example: Company Y (Product Name: Ergonov) – Market presence in North America and Europe.
- Regional Generic Manufacturers: Companies specializing in generic drug production play a significant role in specific geographical markets.
- Example: Company Z (Product Name: Methylergonovine Maleate Tablets) – Strong presence in South America.
- Example: Company W (Product Name: Ergovine) – Key supplier in parts of Africa.
What are the Typical Lead Times for Methylergonovine Maleate API Procurement?
Lead times for API procurement are influenced by manufacturing schedules, existing inventory, and shipping logistics.
- Standard Orders (10-100 kg): Typically 12-16 weeks from order placement to delivery, assuming API availability in the manufacturing facility.
- Larger Volume Orders (100+ kg): May require longer lead times, up to 20-24 weeks, due to production batch scheduling and raw material sourcing.
- Expedited Orders: Possible for a premium price, with potential lead times of 8-10 weeks, subject to supplier capacity and inventory.
What are the Primary Risks in the Methylergonovine Maleate Supply Chain?
The Methylergonovine Maleate supply chain faces several potential risks that could impact availability and price.
- Single-Sourcing Dependency: Reliance on a limited number of API manufacturers creates vulnerability to disruptions at those specific sites.
- Regulatory Changes: Evolving GMP standards or new regulatory requirements in key manufacturing countries can necessitate costly process modifications.
- Geopolitical Instability: Disruptions in countries with high concentrations of API manufacturing can have global ripple effects.
- Raw Material Volatility: The synthesis of Methylergonovine Maleate involves controlled substances and specific chemical precursors, whose availability and pricing can fluctuate.
- Quality Control Failures: Even minor deviations in quality can lead to batch rejection and significant delays.
What is the Pricing Landscape for Methylergonovine Maleate API?
Pricing for Methylergonovine Maleate API is influenced by production volume, supplier, regulatory standing, and market demand.
- High-Volume Contracts (100+ kg): Can range from $250 - $450 per kilogram, depending on the supplier and market conditions.
- Medium-Volume Orders (10-100 kg): Typically priced between $400 - $600 per kilogram.
- Small-Volume or Spot Purchases: Can exceed $700 per kilogram.
These prices are indicative and subject to significant negotiation and fluctuations based on global supply and demand dynamics.
Key Takeaways
The Methylergonovine Maleate API market is characterized by a concentrated global manufacturing base, primarily in Asia, with robust regulatory oversight being a critical factor for supplier selection. Supply chain resilience necessitates strategic sourcing from multiple approved vendors to mitigate risks associated with single-sourcing, geopolitical instability, and potential quality control failures. Lead times for API procurement can extend up to six months for larger volumes, requiring proactive inventory management and long-term contracting.
Frequently Asked Questions
What are the primary uses of Methylergonovine Maleate?
Methylergonovine Maleate is primarily used to prevent or control heavy bleeding after childbirth (postpartum hemorrhage) and after an incomplete or inevitable abortion. It works by causing contractions of the uterus.
How does the synthesis of Methylergonovine Maleate differ from other ergot alkaloids?
The synthesis of Methylergonovine Maleate involves specific chemical modifications of lysergic acid, a core ergot alkaloid structure, to introduce the N-methyl-N-(1-propanol)aminoethyl side chain. This process requires specialized enzymatic or chemical routes to achieve the desired stereochemistry and functional groups.
What are the main challenges in ensuring a stable supply of Methylergonovine Maleate?
Challenges include the reliance on a limited number of skilled API manufacturers, the potential for raw material shortages or price volatility (especially for precursors derived from ergot fungus cultivation), and the stringent regulatory requirements for pharmaceutical production and quality control.
Are there any known supply chain vulnerabilities specific to the ergot alkaloid class of drugs?
Yes, ergot alkaloids are derived from the Claviceps purpurea fungus, which can be subject to agricultural variables, cultivation challenges, and potential contamination. Additionally, the chemistry involved in isolating and synthesizing these complex molecules is specialized, limiting the number of qualified producers.
What is the typical shelf life of Methylergonovine Maleate API?
The typical shelf life for Methylergonovine Maleate API, when stored under recommended conditions (typically cool, dry, and protected from light), is generally between two to three years. This can vary based on the manufacturer's specific stability studies and packaging.
